Drug Formulary Review articles from July 2005

Drug Formulary Review archives from July 2005

Some computerized physician order entry systems are limited, study shows.
July 1, 2005... Some computerized physician order entry systems are limited, study shows Adverse drug events still were high in the decision-support area Researchers examining adverse drug events (ADEs) at a Veterans Affairs (VA) Hospital in Salt Lake...

Joint Commission revises medication safety goals.(Joint Commission on Accreditation of Healthcare Organizations)
July 1, 2005... Joint Commission revises medication safety goals 'Do not use' abbreviation requirement revised The Joint Commission on Accreditation of Healthcare Organizations in Oakbrook Terrace, IL, has announced its 2006 National Patient Safety...

Research News: AE analysis raises safety questions about Crestor.(Adverse Event Reporting System)
July 1, 2005... AE analysis raises safety questions about Crestor Results still show statins are safe, says AHA A review of adverse events reported to the FDA raises concern about the relative safety of rosuvastatin (Crestor) at its commonly used...

News from ASCO.(American Society Clinical Oncology)(anti-angiogenic agent )(Brief Article)
July 1, 2005... News from ASCO Here is news from the 2005 American Society Clinical Oncology (ASCO) Meeting in Orlando, FL, in mid-May: Lenalidomide can replace blood transfusions in bone marrow disorder. Lenalidomide (Revlimid) can help some...

News Briefs.
July 1, 2005... CDC announces strategy for 2005-06 flu season The Centers for Disease Control (CDC) in Atlanta has announced that the supply of inactivated influenza vaccine projected for the 2005-06 season should be adequate to meet the historical demand...

New FDA Approvals.(metformin hydrochloride approved in new formulation)(galsulfase approved for treatment of mucopolysaccharidosis VI)(peginterferon alfa-2a approved for the treatment of chronic hepatitis B)
July 1, 2005... These drugs recently were approved by the FDA: * Metformin hydrochloride (HCl) (Glumetza) by Biovail Corp. and Depomed. The FDA has approved metformin HCl (Glumetza), a once-daily, extended-release formulation for the treatment of Type II...

Drug Criteria & Outcomes: Ziconotide (Prialt) Formulary Evaluation.
July 1, 2005... .table { border-collapse: collapse; border-color: #000000; } Drug Criteria & Outcomes Ziconotide (Prialt) Formulary Evaluation Part 1 of 2: Similar Drugs in Class, Comparative Agent, Mechanism of Action, Strengths/Dosage,...

CE Questions.
July 1, 2005... CE Questions Pharmacists participate in this continuing education program by reading the article, using the provided references for further research, and studying the CE questions. Participants should select what they believe to be the...